Biodesix (NASDAQ:BDSX) versus First Choice Healthcare Solutions (OTCMKTS:FCHS) Critical Survey

First Choice Healthcare Solutions (OTCMKTS:FCHS) and Biodesix (NASDAQ:BDSX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, analyst recommendations, valuation and risk.

Insider and Institutional Ownership

21.0% of Biodesix shares are held by institutional investors. 30.8% of First Choice Healthcare Solutions shares are held by company insiders. Comparatively, 69.2% of Biodesix shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations and price targets for First Choice Healthcare Solutions and Biodesix, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
First Choice Healthcare Solutions	0	0	0	0	0.00
Biodesix	0	0	5	0	3.00

Biodesix has a consensus target price of $3.06, indicating a potential upside of 285.88%. Given Biodesix’s stronger consensus rating and higher possible upside, analysts clearly believe Biodesix is more favorable than First Choice Healthcare Solutions.

Volatility & Risk

First Choice Healthcare Solutions has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Comparatively, Biodesix has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500.

Profitability

This table compares First Choice Healthcare Solutions and Biodesix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
First Choice Healthcare Solutions	-9,943.78%	N/A	-123.38%
Biodesix	-66.84%	-275.79%	-43.05%

Earnings and Valuation

This table compares First Choice Healthcare Solutions and Biodesix”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
First Choice Healthcare Solutions	$30,000.00	7.36	-$8.17 million	N/A	N/A
Biodesix	$65.56 million	1.76	-$52.15 million	($0.39)	-2.03

First Choice Healthcare Solutions has higher earnings, but lower revenue than Biodesix.

Summary

Biodesix beats First Choice Healthcare Solutions on 9 of the 12 factors compared between the two stocks.

About First Choice Healthcare Solutions

First Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.

About Biodesix

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.